Other grades of this product :
| Product Name: | XL-647 | | Synonyms: | Tesevatinib;Tesevatinib(XL647);XL-647;N-(3,4-dichloro-2-fluorophenyl)-6-Methoxy-7-(((3aR,6aS)-2-Methyloctahydrocyclopenta[c]pyrrol-5-yl)Methoxy)quinazolin-4-aMine;N-(3,4-Dichloro-2-fluorophenyl)-6-methoxy-7-[[(3aalpha,5beta,6aalpha)-octahydro-2-methylcyclopenta[c]pyrrol-5-yl]methoxy]-4-quinazolinamine;EXEL-7647;XL-647;XL 647;KD-019;Rel-N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-2-methyloctahydrocyclopenta[c]pyrrol-5-yl)methoxy)quinazolin-4-amine | | CAS: | 781613-23-8 | | MF: | C24H25Cl2FN4O2 | | MW: | 491.3853032 | | EINECS: | | Product Categories: | | Mol File: | 781613-23-8.mol |
| XL-647 Chemical Properties |
| Boiling point | 567.9±50.0 °C(Predicted) | | density | 1.356 | | pka | 10.16±0.40(Predicted) |
| XL-647 Usage And Synthesis |
| Uses | XL 647 is a potent and selective EGFR phosphorylation inhibitor and may be used in the treatment of patients suffering from lung cancer. Orally available, multi-target tyrosine kinase inhibitor. |
| XL-647 Preparation Products And Raw materials |
|
日本语
한국어
Français
Deutsch
España
Türkiye